![Jeff Miller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeff Miller
Directeur/Bestuurslid bij
BIOTECanada
Profiel
Jeff Miller is a board member at BIOTECanada and a business advisor at Dreavent, Inc. He previously worked as a director at Boehringer Ingelheim GmbH from 2005 to 2009, as a vice president at EMD Serono, Inc. from 2012 to 2014, and as a vice president at Alnylam Pharmaceuticals, Inc. in 2018.
Mr. Miller received his undergraduate degree from State University of New York College at Oswego in 1994 and his MBA from Questrom School of Business in 1996.
Actieve functies van Jeff Miller
| Bedrijven | Functie | Begin |
|---|---|---|
Dreavent, Inc.
 Dreavent, Inc. Investment ManagersFinance Dreavent invests in companies located in the United States. The firm targets companies operating in the fields of healthcare, biotech and life science sectors. It provides financing for early and later stage capital requirements. | Consultant / Adviseur | 01-03-2023 |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Directeur/Bestuurslid | 01-05-2020 |
Eerdere bekende functies van Jeff Miller
| Bedrijven | Functie | Einde |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Private Equity Investor | 01-06-2018 |
EMD Serono, Inc.
 EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Private Equity Investor | 01-01-2014 |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Corporate Officer/Principal | 01-01-2009 |
Opleiding van Jeff Miller
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
80
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Health Technology |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
State University of New York College at Oswego
 State University of New York College at Oswego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Health Technology |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Questrom School of Business
 Questrom School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dreavent, Inc.
Dreavent, Inc. Investment ManagersFinance Dreavent invests in companies located in the United States. The firm targets companies operating in the fields of healthcare, biotech and life science sectors. It provides financing for early and later stage capital requirements. | Finance |
